Skip to content

Using Immersive Virtual Reality for Cognitive Therapy in Elderly with Mild Cognitive Impairment

Utilization of Immersive Virtual Reality in Cognitive Stimulation Therapy (IVR-CST) for Elderly with Mild Cognitive Impairment: a Randomized Controlled Pilot Study

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06838494
Acronym
VR-CST-MCI
Enrollment
66
Registered
2025-02-20
Start date
2025-07-03
Completion date
2027-04-30
Last updated
2025-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Cognitive Impairment (MCI)

Keywords

Mild Cognitive Impairment (MCI), Cognitive stimulation therapy, immersive reality, Eye-tracking

Brief summary

The proposed study aims to investigate the potential of IVR-CST in improving cognition of people with MCI, and as well the association of eye movement during therapy and treatment outcomes of IVR-CST. Four research questions have been proposed and listed as follows: 1. Is IVR-CST a feasible treatment for elderly with MCI? 2. Is IVR-CST an efficacious treatment for improving cognition of elderly with MCI? 3. Is IVR-CST more efficacious than conventional CST (i.e., without IVR) in improving the cognition of elderly with MCI? 4. Is eye-tracking data collected during therapy associated with treatment outcomes of IVR CST?

Interventions

BEHAVIORALIVR-CST (Immersive Virtual Reality Cognitive Stimulation Therapy)

IVR-CST involves 14 sessions of cognitive stimulation therapy conducted twice a week in a virtual reality environment. Each session lasts approximately 45 minutes and utilizes head-mounted displays (HMDs) to immerse participants in engaging, themed activities. The therapy aims to enhance cognitive function and social interaction through interactive and stimulating virtual experiences tailored for individuals with mild cognitive impairment (MCI).

BEHAVIORALIntervention Name: Conventional CST (Cognitive Stimulation Therapy)

Conventional CST consists of 14 sessions of cognitive stimulation therapy conducted twice a week, each lasting about 45 minutes. In this arm, participants engage in group activities using physical materials, such as photos, pictures, and real objects, rather than virtual reality. The therapy focuses on providing cognitive stimulation through discussions and activities designed to improve cognitive function and social engagement among individuals with mild cognitive impairment (MCI).

Sponsors

The University of Hong Kong
CollaboratorOTHER
University of Reading
CollaboratorOTHER
Johns Hopkins University
CollaboratorOTHER
The Hong Kong Polytechnic University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. elderly aged 60 years or above, 2. a diagnosis of MCI made by a psychiatrist, or a score of 16-21 out of 30 in the Hong Kong Brief Cognitive Test (HKBC, 31), with upper and lower cutoff scores for MCI as suggested by the test. HKBC has been validated in Hong Kong with satisfactory sensitivity (0.88) and specificity ((0.81) in differentiating subjects with MCI and healthy individuals, 3. ability to speak and comprehend Cantonese, 4. normal or corrected-to-normal binocular vision and hearing, 5. absence of physical illness/disability to prevent them from IVR-CST participation, 6, compatible with IVR exposure in the 10-minute IVR trial without major signs of cybersickness, based on the symptoms given in the Simulator Sickness Questionnaire

Exclusion criteria

1. concurrent participation in other clinical therapy trials, 2. incompatibility with IVR exposure such as complaints of nausea, headache, or other severe discomforts during trial use, 3. a diagnosis of dementia or other psychiatric/neurological diseases such as depression, stroke, brain trauma, Parkinson's disease 4. hearing/visual/upper limb impairments that hinder CST/IVR-CST participation, 5. prior CST treatment, 6. Use of medication for MCI/dementia, e.g., aducanumab

Design outcomes

Primary

MeasureTime frameDescription
Hong Kong Montreal Cognitive Assessment (HK-MoCA)From 1-week pre-intervention to 13 weeks post-interventionHong Kong Montreal Cognitive Assessment (HK-MoCA) Measurement of global cognition in participants, covering various cognitive domains such as visuo-spatial skills, executive functions, attention, memory, language, and orientation. The total score ranges from 1-30, with higher score indicating better performance.
Digit Span Forward and Backward TasksFrom 1-week pre-intervention to 13 weeks post-interventionAssessment of working memory capacity, predicting progression from MCI to dementia. The test will start from 1 digit with increasing number of digit to increase level of difficulty.
Verbal Fluency of Semantic CategoryFrom 1-week pre-intervention to 13 weeks post-interventionEvaluation of semantic integrity, cognitive flexibility, and executive function by measuring the number of items correctly produced in one minute across different semantic categories (animals, fruits, transportation).

Secondary

MeasureTime frameDescription
Chinese Version of the Modified Barthel IndexFrom 1-week pre-intervention to 13 weeks post-interventionAssessment of the level of independence in activities of daily living, including grooming, feeding, mobility, toileting, and more. The test score ranges from 1-100 with higher scores indicating better performance.
Semi-Structured Interview for IVR-CST GroupImmediately post-interventionPost-therapy interview assessing comfort levels, presence of adverse effects (e.g., cybersickness), and the impact of therapy on daily functions. Conducted by a trained research assistant in a quiet clinical room, with the session audio-taped.
Hong Kong Lawton Instrumental Activities of Daily Living ScaleFrom 1-week pre-intervention to 13 weeks post-interventionEvaluation of independence in performing community-living skills, such as cooking, household management, and shopping. The test score ranged from 0-18 and a higher score indicates better performance.
Feasibility Outcomes and Users' ExperienceThroughout the intervention period (from weeks 1-7 of intervention)Objective measures of feasibility, including the number of adverse events and technical issues during the intervention, as well as adherence to the intervention protocol (actual duration and number of sessions conducted vs. scheduled).

Countries

Hong Kong

Contacts

Primary ContactWinsy WS Wong, PHD
wszewong@polyu.edu.hk852-34003117

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026